1186 SAFETY AND ANTIVIRAL ACTIVITY OF ABT-267, A NOVEL NS5A INHIBITOR, DURING 3-DAY MONOTHERAPY: FIRST STUDY IN HCV GENOTYPE-1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS

✍ Scribed by Lawitz, E.; Marbury, T.; Campbell, A.; Dumas, E.; Kapoor, M.; Pilot-Matias, T.; Krishnan, P.; Setze, C.; Xie, W.; Podsadecki, T.; Bernstein, B.; Williams, L.

• Book ID: 123099473
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 118 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61198-2